Buchumschlag

Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis

Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. - Background - Non-insulin-dependent diabetes mellitus dialysis patients have the highest cardiovascular mortality known in any group of patients. Mixed dyslipidemia with moderately elevated low-density lipoprotei...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wanner, Christoph (VerfasserIn) , Krane, Vera (VerfasserIn) , Ruf, Günther (VerfasserIn) , März, Winfried (VerfasserIn) , Ritz, Eberhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 July 1999
In: Kidney international
Year: 1999, Jahrgang: 56, Pages: S222-S226
ISSN:1523-1755
DOI:10.1046/j.1523-1755.1999.07158.x
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1046/j.1523-1755.1999.07158.x
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0085253815466463
Volltext
Verfasserangaben:Christoph Wanner, Vera Krane, Günther Ruf, Winfried März, and Eberhard Ritz
Beschreibung
Zusammenfassung:Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. - Background - Non-insulin-dependent diabetes mellitus dialysis patients have the highest cardiovascular mortality known in any group of patients. Mixed dyslipidemia with moderately elevated low-density lipoprotein (LDL) cholesterol and high levels of triglyceride-rich lipoproteins is common in this condition. It is not known, however, whether patients with type 2 diabetes on dialysis with this form of dyslipidemia derive benefit from lipid-lowering therapy. Recently, drugs have become available that potently lower triglyceride-rich, apoB-containing lipoproteins and thus permit testing of this issue. This is the first trial to address specifically the issue of whether the excessive cardiovascular mortality of patients with type 2 diabetes on dialysis can be lowered by statins.
Beschreibung:Gesehen am 28.10.2021
Beschreibung:Online Resource
ISSN:1523-1755
DOI:10.1046/j.1523-1755.1999.07158.x

Ähnliche Einträge